RHUMBLINE ADVISERS - Y-MABS THERAPEUTICS INC ownership

Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 100 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of Y-MABS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$299,126
-16.5%
54,887
+4.0%
0.00%
Q2 2023$358,437
+146800.4%
52,789
+8.5%
0.00%
Q1 2023$244
+2.5%
48,634
-0.2%
0.00%
Q4 2022$238
-100.0%
48,749
+4.2%
0.00%
-100.0%
Q3 2022$675,000
+2.6%
46,805
+7.6%
0.00%0.0%
Q2 2022$658,000
+53.4%
43,511
+20.6%
0.00%0.0%
Q1 2022$429,000
-27.3%
36,092
-0.9%
0.00%0.0%
Q4 2021$590,000
-44.2%
36,417
-1.6%
0.00%0.0%
Q3 2021$1,057,000
-10.7%
37,022
+5.7%
0.00%
-50.0%
Q2 2021$1,184,000
+9.7%
35,021
-1.9%
0.00%
+100.0%
Q1 2021$1,079,000
-43.4%
35,696
-7.3%
0.00%
-66.7%
Q4 2020$1,906,000
+35.9%
38,496
+5.3%
0.00%
+50.0%
Q3 2020$1,403,000
-22.4%
36,555
-12.7%
0.00%
-33.3%
Q2 2020$1,809,000
+147.1%
41,875
+49.3%
0.00%
+50.0%
Q1 2020$732,000
-14.0%
28,048
+3.0%
0.00%
+100.0%
Q4 2019$851,000
+48.0%
27,222
+23.4%
0.00%0.0%
Q3 2019$575,000
+17.3%
22,053
+2.9%
0.00%0.0%
Q2 2019$490,00021,4370.00%
Other shareholders
Y-MABS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 191,176$2,271,0002.63%
Sofinnova Investments, Inc. 2,194,278$26,068,0001.98%
MPM BioImpact LLC 443,702$5,271,0001.42%
Soleus Capital Management, L.P. 238,982$2,839,0000.37%
Lombard Odier Asset Management (Switzerland) SA 221,774$2,635,0000.21%
Artal Group S.A. 400,000$4,752,0000.20%
Polar Capital Holdings Plc 2,877,671$34,187,0000.15%
ASHFORD CAPITAL MANAGEMENT INC 106,770$1,268,0000.14%
Cormorant Asset Management, LP 150,000$1,782,0000.14%
Virtus ETF Advisers LLC 23,646$281,0000.13%
View complete list of Y-MABS THERAPEUTICS INC shareholders